Medicare Enrolled
Dr. Philip Benyo, MD
Internal Medicine · Sugarloaf, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Benyo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benyo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Benyo
Dr. Philip Benyo is an internal medicine specialist in Sugarloaf, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Benyo performed 7,781 Medicare services across 2,502 unique beneficiaries.
Between the years covered by Open Payments, Dr. Benyo received a total of $11,972 from 60 pharmaceutical and/or device companies across 834 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Benyo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 1% volume in PA
$11,972 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,781
Medicare services
Top 1% in PA for internal medicine
2,502
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~371 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $47 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
526 | $125 | $215 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $85 | $210 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
390 | $51 | $166 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
270 | $9 | $65 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
270 | $53 | $136 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
194 | $62 | $151 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
193 | $1 | $10 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
189 | $37 | $99 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
157 | $155 | $327 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
95 | $29 | $56 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
92 | $78 | $179 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
82 | $70 | $150 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
74 | $83 | $250 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
73 | $9 | $50 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
56 | $48 | $180 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
40 | $142 | $342 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
40 | $120 | $288 |
| Home visit, new patient, low complexity A home visit for a new patient involving a low level of medical decision making. The visit lasts at least 30 minutes when time is used to determine the level of service. |
35 | $54 | $163 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
34 | $30 | $110 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
25 | $38 | $80 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
25 | $123 | $260 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
23 | $64 | $135 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $33 | $87 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
19 | $113 | $349 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $6 | $15 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
18 | $161 | $291 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
17 | $31 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $121 | $316 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $69 | $207 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
13 | $104 | $254 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
13 | $29 | $46 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
12 | $49 | $160 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
12 | $16 | $45 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
12 | $11 | $77 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
11 | $282 | $535 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
11 | $103 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2023 ↗$11,972
Total received (2018-2023)
Avg $1,995/year across 6 years
Top 7% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
834
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,972 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$2,558
2022
$2,361
2021
$2,420
2020
$1,396
2019
$1,494
2018
$1,743
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$383
Amgen Inc.
$376
Lilly USA, LLC
$289
AbbVie Inc.
$266
PFIZER INC.
$201
Mylan Specialty L.P.
$166
Teva Pharmaceuticals USA, Inc.
$99
Shield Therapeutics Inc
$81
Novartis Pharmaceuticals Corporation
$81
Exact Sciences Corporation
$77
Bayer Healthcare Pharmaceuticals Inc.
$67
GlaxoSmithKline, LLC.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Xeris Pharmaceuticals, Inc.
$49
E.R. Squibb & Sons, L.L.C.
$45
NESTLE HEALTHCARE NUTRITION INC.
$38
Axonics, Inc.
$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$29
IDORSIA PHARMACEUTICALS US INC
$29
UCB, Inc.
$28
Alexion Pharmaceuticals, Inc.
$28
Lundbeck LLC
$17
SANOFI-AVENTIS U.S. LLC
$17
Otsuka America Pharmaceutical, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$13
AstraZeneca Pharmaceuticals LP
$13
Top 3 companies account for 41.0% of 2023 payments
All-time payments by company (2018-2023) ›
Amgen Inc.
$1,796
Novo Nordisk Inc
$1,730
PFIZER INC.
$1,090
Lilly USA, LLC
$772
AstraZeneca Pharmaceuticals LP
$697
Novartis Pharmaceuticals Corporation
$475
GlaxoSmithKline, LLC.
$446
Boehringer Ingelheim Pharmaceuticals, Inc.
$403
AbbVie Inc.
$390
Merck Sharp & Dohme Corporation
$324
SANOFI-AVENTIS U.S. LLC
$306
Mylan Specialty L.P.
$302
Teva Pharmaceuticals USA, Inc.
$225
Janssen Pharmaceuticals, Inc
$219
ABBVIE INC.
$207
Amarin Pharma Inc.
$175
Nestle HealthCare Nutrition Inc.
$166
Biogen, Inc.
$162
E.R. Squibb & Sons, L.L.C.
$160
UCB, Inc.
$157
Bayer HealthCare Pharmaceuticals Inc.
$140
Kowa Pharmaceuticals America, Inc.
$137
Merck Sharp & Dohme LLC
$90
Shield Therapeutics Inc
$81
Exact Sciences Corporation
$77
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$74
Alexion Pharmaceuticals, Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$67
Esperion Therapeutics, Inc.
$63
Astellas Pharma US Inc
$58
Radius Health, Inc.
$56
Biohaven Pharmaceuticals, Inc.
$50
IBSA Pharma Inc.
$50
Xeris Pharmaceuticals, Inc.
$49
Avanir Pharmaceuticals, Inc.
$48
Otsuka America Pharmaceutical, Inc.
$47
Biohaven Pharmaceutical Holding Company Ltd.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$42
NESTLE HEALTHCARE NUTRITION INC.
$38
Sunovion Pharmaceuticals Inc.
$35
Abbott Laboratories
$35
Phadia US Inc.
$31
Scilex Pharmaceuticals Inc.
$31
Smith+Nephew, Inc.
$31
Axonics, Inc.
$29
IDORSIA PHARMACEUTICALS US INC
$29
Ardelyx, Inc.
$26
Eisai Inc.
$26
AbbVie, Inc.
$26
Purdue Pharma L.P.
$23
Noden Pharma USA Inc
$23
Paratek Pharmaceuticals, Inc.
$22
Valeritas, Inc.
$19
Antares Pharma, Inc.
$19
Lundbeck LLC
$17
Sanofi Pasteur Inc.
$15
ACADIA Pharmaceuticals Inc
$14
Allergan Inc.
$13
Allergan, Inc.
$11
BioDelivery Sciences International, Inc.
$11
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADUHELM · AJOVY · AMYVID · ANORO · ANORO ELLIPTA · AREXVY · AUSTEDO · Aimovig · Austedo XR · Axonics · BAQSIMI · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREZTRI · BUNAVAIL 2.1 mg 30-count box · BYDUREON · Briviact · CHANTIX · COLLAGENASE SANTYL · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cologuard Collection Kit · Corlanor · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FIASP · FreeStyle Libre 2 · GARDASIL 9 · GVOKE HYPOPEN · IBSRELA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MENACTRA · MOUNJARO · MYRBETRIQ · Motegrity · NEXLETOL · NOCDURNA · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · Nayzilam · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Perforomist · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNJARDY · SYNTHROID · Santyl · Saxenda · Synthroid · TEKTURNA · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · ULTOMIRIS · Ultomiris · Utibron · V-GO · VIAGRA · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · YUPELRI · Yupelri · ZENPEP · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in PA.
Geographic Context
Internal medicine physicians within 10 mi
131
Per 100K population
40.2
County median income
$62,321
Nearest hospital
LEHIGH VALLEY HOSPITAL - HAZLETON
8.8 mi
8.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Benyo is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 7% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Benyo experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Benyo performed 4,200 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benyo receive payments from pharmaceutical companies?
Yes. Dr. Benyo received a total of $11,972 from 60 companies across 834 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benyo's costs compare to other internal medicine physicians in Sugarloaf?
Dr. Benyo's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benyo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Sugarloaf
Browse internal medicine physicians in Sugarloaf ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology